161 related articles for article (PubMed ID: 35634442)
1. Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy.
Zhang Y; Zhao J; Wang Y; Cai W; Zhang X; Li K; Liu W; Zhao Y; Kang H
Dis Markers; 2022; 2022():7739777. PubMed ID: 35634442
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of serum biomarkers CA153, CEA, and white blood cells in predicting sentinel lymph node metastasis of breast cancer.
Fan Y; Chen X; Li H
Int J Clin Exp Pathol; 2020; 13(11):2889-2894. PubMed ID: 33284901
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
[TBL] [Abstract][Full Text] [Related]
4. The association of five preoperative serum tumor markers and pathological features in patients with breast cancer.
Lian M; Zhang C; Zhang D; Chen P; Yang H; Yang Y; Chen S; Hong G
J Clin Lab Anal; 2019 Jun; 33(5):e22875. PubMed ID: 30843272
[TBL] [Abstract][Full Text] [Related]
5. Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.
Zhao S; Mei Y; Wang J; Zhang K; Ma R
PLoS One; 2016; 11(6):e0157639. PubMed ID: 27327081
[TBL] [Abstract][Full Text] [Related]
6. The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Yu S; Zhao J; Wang M; Cheng G; Li W; Tang L; Yao S; Pang L; Yin X; Jing Y; Cheng H
Front Med (Lausanne); 2022; 9():945433. PubMed ID: 36091709
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
Zhao FL; Dou YC; Wang XF; Han DC; Lv ZG; Ge SL; Zhang YK
Mol Biol Rep; 2014 Sep; 41(9):5913-22. PubMed ID: 25103018
[TBL] [Abstract][Full Text] [Related]
8. Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations.
Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
Zheng H; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of color Doppler ultrasound combined with serum CA153, CEA and TSGF detection in the diagnosis of breast cancer.
Song X; Liang B; Wang C; Shi S
Exp Ther Med; 2020 Aug; 20(2):1822-1828. PubMed ID: 32742414
[TBL] [Abstract][Full Text] [Related]
11. Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.
Jia L; Li G; Ma N; Zhang A; Zhou Y; Ren L; Dong D
BMC Cancer; 2022 Jul; 22(1):760. PubMed ID: 35831854
[TBL] [Abstract][Full Text] [Related]
12. Strategies for five tumour markers in the screening and diagnosis of female breast cancer.
Luo J; Xiao J; Yang Y; Chen G; Hu D; Zeng J
Front Oncol; 2022; 12():1055855. PubMed ID: 36755860
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of postoperative neutrophil-to-lymphocyte ratio, D-dimer, and CA153 in: Diagnostic value for recurrent and metastatic breast cancer.
Ren Z; Yang J; Liang J; Xu Y; Lu G; Han Y; Zhu J; Tan H; Xu T; Ren M
Front Surg; 2022; 9():927491. PubMed ID: 36684341
[TBL] [Abstract][Full Text] [Related]
14. Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease.
Yau T; Wong H; Chan P; Chan T; Mak J; Epstein RJ
Clin Colorectal Cancer; 2010 Apr; 9(2):108-12. PubMed ID: 20378505
[TBL] [Abstract][Full Text] [Related]
15. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.
Gao J; Zhang Q; Xu J; Guo L; Li X
Chin J Cancer Res; 2013 Dec; 25(6):743-8. PubMed ID: 24385703
[TBL] [Abstract][Full Text] [Related]
17. Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis.
Jiang X; Guo D; Li W; Yu T; Zhou J; Gong J
Mol Med Rep; 2017 Mar; 15(3):1123-1134. PubMed ID: 28112378
[TBL] [Abstract][Full Text] [Related]
18. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
[TBL] [Abstract][Full Text] [Related]
20. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.
Arslan N; Serdar M; Deveci S; Ozturk B; Narin Y; Ilgan S; Ozturk E; Ozguven MA
Ann Nucl Med; 2000 Oct; 14(5):395-9. PubMed ID: 11108173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
